<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/403683</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;403683v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;403683</article-id><article-id pub-id-type="other" hwp:sub-type="slug">403683</article-id><article-id pub-id-type="other" hwp:sub-type="tag">403683</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Confirmatory Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Epidemiology" hwp:journal="biorxiv"><subject>Epidemiology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">General aspects of visceral leishmaniasis with or without HIV co-infection in Northeast Brazil</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>*</label>E-mail of the corresponding author: <email hwp:id="email-1">conceicaopedrozo@gmail.com</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Silva de Lima Uiara Regina"><surname>Silva de Lima</surname><given-names>Uiara Regina</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Vanolli Luciano"><surname>Vanolli</surname><given-names>Luciano</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Moraes Elizabeth Coelho"><surname>Moraes</surname><given-names>Elizabeth Coelho</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Ithamar Jorim Severino"><surname>Ithamar</surname><given-names>Jorim Severino</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-5"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0712-1852</contrib-id><name name-style="western" hwp:sortable="Silva de Azevedo e Conceição de Maria Pedrozo e"><surname>Silva de Azevedo</surname><given-names>e Conceição de Maria Pedrozo e</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0003-0712-1852"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2"><label>1</label><institution hwp:id="institution-1">Post-graduation Program of Health Science, Federal University of Maranhão</institution>, São Luís, MA, <country>Brazil</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1"><label>2</label><institution hwp:id="institution-2">Department of Medicine, Federal University of Maranhão</institution>, São Luãs, MA, <country>Brazil</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2"><label>3</label><institution hwp:id="institution-3">Medicine Graduate Program, Federal University of Maranhão</institution>, São Luís, MA, <country>Brazil</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1"><label>4</label><institution hwp:id="institution-4">President Vargas Hospital</institution>, São Luís, MA, <country>Brazil</country></aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2018"><year>2018</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-08-29T07:33:10-07:00">
    <day>29</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2018-08-29T07:33:10-07:00">
    <day>29</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-08-29T07:39:46-07:00">
    <day>29</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2018-08-29T07:39:46-07:00">
    <day>29</day><month>8</month><year>2018</year>
  </pub-date><elocation-id>403683</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-08-29"><day>29</day><month>8</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2018-08-29"><day>29</day><month>8</month><year>2018</year></date>
<date date-type="accepted" hwp:start="2018-08-29"><day>29</day><month>8</month><year>2018</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2018</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/" hwp:id="license-1"><p hwp:id="p-1">This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by/4.0/</ext-link></p></license></permissions><self-uri xlink:href="403683.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/403683v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="403683.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/403683v1/403683v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/403683v1/403683v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">ABSTRACT</title><sec hwp:id="sec-1"><title hwp:id="title-2">Background</title><p hwp:id="p-2">The case of visceral leishmaniasis (VL) and human immunodeficiency virus (HIV) co-infection was reported in Spain first in 1985, and coincidence of these diseases has also been confirmed in more than 35 countries.</p></sec><sec hwp:id="sec-2"><title hwp:id="title-3">Methodology</title><p hwp:id="p-3">We performed a comparative study in the state’s reference hospital for infectious/parasitic diseases, which treats adults with HIV/acquired immune deficiency syndrome (AIDS), between January 2007 and July 2017. The data obtained using this protocol were analyzed using SPSS.</p></sec><sec hwp:id="sec-3"><title hwp:id="title-4">Principal findings</title><p hwp:id="p-4">In total, 163 patients were evaluated in this study, including 126 patients with coincident VL/HIV and 37 patients with VL alone. Both groups consisted primarily of male patients. The most commonly affected age group was 30–39 years (<italic toggle="yes">p</italic> &lt; 0.001). Fever (<italic toggle="yes">p</italic> &lt; 0.001) and hair loss (<italic toggle="yes">p</italic> = 0.007), which were more common in patients with VL alone, were more common. On hemogram, segmented neutrophils (<italic toggle="yes">p</italic> &lt; 0.0001) were found to be more in the VL/HIV group than in the VL alone group. Additionally, AST and ALT levels differed between the groups (<italic toggle="yes">p</italic> &lt; 0.001). On average, HIV was diagnosed 2.6 years before VL (<italic toggle="yes">p</italic> &lt; 0.001). VL relapse was observed only in the co-infection group (36.5% of cases). Fever (<italic toggle="yes">β</italic> = +0.17; <italic toggle="yes">p</italic> = 0.032) in the first VL/HIV episode was identified as a risk factor for relapse (<italic toggle="yes">R</italic><sup>2</sup> = 0.18). The death rate of co-infected patients was 11.1%.</p></sec><sec hwp:id="sec-4"><title hwp:id="title-5">Conclusion/Significance</title><p hwp:id="p-5">VL/HIV was prevalent among young adults, whereas the median patient age was higher in the VL group. The classic symptomatology of VL was more common in patients not co-infected with HIV, but attention is needed regarding the presence of fever in the first episode of VL as a risk factor for relapse in co-infected patients. No cases of VL relapse occurred in patients without HIV.</p></sec><sec hwp:id="sec-5"><title hwp:id="title-6">AUTHOR SUMMARY</title><p hwp:id="p-6">Visceral Leishmaniasis (VL) and HIV have maintained increasing rates of populational occurrence in the Northeast region of Brazil, with advancing in rural areas and VL advancing in urban areas. This dynamic explains the increase of co-infection from 0.7% in 2001 to 8.5% in 2012. The state of Maranhão presents a large number of cases in the Northeast Brazil, a region with the majority of patients with this co-infection. The severity presented by these patients, in the observation of frequent relapses and high lethality, is presented in this study, which contributes to epidemiological, clinical, laboratorial, and evolutionary knowledge, trying to demonstrate these in the statistical data. Therefore, it should be pointed out that young adult patients with HIV/AIDS who present with any cytopenia, with or without hepatosplenomegaly and accompanied by fever or not, must be investigated for VL.</p></sec></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><title hwp:id="title-7">Keywords</title><kwd hwp:id="kwd-1">Visceral leishmaniasis</kwd><kwd hwp:id="kwd-2">HIV/AIDS</kwd><kwd hwp:id="kwd-3">co-infection</kwd></kwd-group><counts><page-count count="27"/></counts></article-meta></front><body><sec id="s1" hwp:id="sec-6"><title hwp:id="title-8">INTRODUCTION</title><p hwp:id="p-7">Visceral leishmaniasis (VL) is an infectious parasitic disease transmitted by <italic toggle="yes">Lutzomyia longipalpis</italic>, with <italic toggle="yes">Leishmania infantum chagasi</italic> being the main causative agent in South America [<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>]. The clinical features of VL may evolve with severity, thus requiring early diagnosis to avoid further complications [<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>]. In Brazil, 634,051 cases of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) had been registered through June 2016 [<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>]. HIV continues to spread across Brazil, and its incidence in countryside locations has been increasing. This explains its association with other endemic diseases, such as VL, which has also increased in frequency in urban locations, thereby accelerating the clinical evolution of both HIV and VL due to cumulative immunosuppression [<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>,<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>]. On the basis of altered epidemiological profiles of both HIV and VL, the risk of exposure to the diseases has grown, with the risk of an HIV-infected person developing VL surging by 100–2320-fold in endemic areas. Moreover, co-infected patients also have reduced responses to therapy, thus resulting in increased risks of recurrence and mortality [<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref>]. The first case of VL/HIV co-infection was reported in 1985, increasing attention in Mediterranean and northern European countries regarding the possibility of this association and the gravity of both diseases [<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>]. By 2007, 35 countries had already reported cases of VL/HIV co-infection [<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref>]. In Brazil, co-infection was first reported in 1990 in a patient from the Northeast region [<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>]. In 2015, 257 cases of co-infection VL/HIV were reported in the Western hemisphere, corresponding to a rate of 7.4% of co-infection between all VL cases. Among these, most cases (244) were recorded in Brazil [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>]. In 2017, a descriptive and exploratory study that analyzed data from all 21 Brazilian states that had reported cases of VL over a 10-year period identified 1301 cases of VL/HIV co-infection. The researchers noticed an increase in the number of VL/HIV cases over time [<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>]. Of these states, 4608 cases of VL were recorded in Maranhão, including 256 cases of HIV co-infection [<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>]. One study performed in the Reference Hospital for Infectious and Parasitic Diseases in Maranhão identified 61 patients with VL/HIV co-infection over a period of 7 years [<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>]. Considering the high incidence rates of VL in Maranhão and the need to improve knowledge about this pathology, especially epidemiological, clinical, and laboratory data related to VL/HIV co-infection, this study sought to identify particularities in the clinical and laboratory presentation of VL irrespective of its association with HIV. This information may contribute to improving the diagnosis and therapeutic management of patients with VL/HIV co-infection.</p></sec><sec id="s2" hwp:id="sec-7"><title hwp:id="title-9">METHODS</title><sec id="s2a" hwp:id="sec-8"><title hwp:id="title-10">Type of study, location, and population</title><p hwp:id="p-8">This comparative study of adults, who are at least 18 years old, was conducted between January 2007 and July 2017 and divided into two steps: (i) a retrospective study of patients diagnosed with VL/HIV co-infection between 2007 and 2015 and (ii) a prospective study of co-infected patients diagnosed between 2016 and 2017. Data were also collected retrospectively from the records of patients with VL without HIV co-infection who were treated at the hospital during the study period. A protocol sheet adapted from the monitoring and control handbook for VL from the Health Ministry, which was named the investigation sheet of death from VL, was used [<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref>]. The sheet was used to record the following variables: sociodemographic (sex, age, occupation, place of residence), epidemiological (place of contamination, other places of residence in the last 12 months), background (other diseases and treatment used), and physical evaluation variables (hydration level, abdominal protrusion, hepatosplenomegaly, swelling); treatment for HIV and leishmaniasis; laboratory examinations (complete blood count, AST, ALT, urea, creatinine, glycemia, CD4 T-lymphocyte count, viral load, bone marrow test); and disease evolution (recurrence, death, hospital release). A case was considered new when the patient had no history or previous record of VL, and deemed recurrent otherwise. The study was conducted at Maranhão’s reference hospital for infectious parasitic diseases, which serves the adult population, including approximately 4640 patients with HIV/AIDS each month.</p></sec><sec id="s2b" hwp:id="sec-9"><title hwp:id="title-11">Inclusion criteria</title><p hwp:id="p-9">The retrospective study included patients with records of VL irrespective of HIV co-infection, containing complete epidemiological, clinical, and laboratory data. Meanwhile, the prospective study included patients with positive serology for HIV and a parasitological diagnosis of VL who were receiving treatment for co-infection at the reference hospital. Meanwhile, the VL group consisted of patients with a parasitological diagnosis of VL and negative serology for HIV who were treated at the reference hospital. All patients included in the prospective study provided written informed consent for participation.</p></sec><sec id="s2c" hwp:id="sec-10"><title hwp:id="title-12">Diagnosis</title><sec id="s2c1" hwp:id="sec-11"><title hwp:id="title-13">Visceral Leishmaniasis</title><p hwp:id="p-10"><italic toggle="yes">Parasitological</italic>: VL was indicated by the presence of the causative parasite in bone marrow (amastigote forms seen in smears aspirated from bone marrow, stained by Giemsa) [<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>]. <italic toggle="yes">Serological</italic>: The indirect fluorescent antibody test has been widely used for diagnosing VL, and it is currently provided by Brazil’s Unified Health System. Its sensitivity ranges from 82 to 95%, and its specificity ranges from 78 to 92% [<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref>,<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>]. Another method used enzyme-linked immunosorbent assay (ELISA), which has sensitivity of 90–100% [<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref>].</p></sec><sec id="s2c2" hwp:id="sec-12"><title hwp:id="title-14">HIV</title><p hwp:id="p-11">HIV was diagnosed using ELISA and the HIV rapid test, which are routinely performed at the reference state hospital following recommendations from the Health Ministry. Other laboratory data used as reference were obtained using the automated system CELL DYN 4000 provided by CEDRO, São Luís, MA, 2002.</p></sec><sec id="s2c3" hwp:id="sec-13"><title hwp:id="title-15">Statistical analyses</title><p hwp:id="p-12">Data were processed using SPSS software version 18.0 (IBM, Chicago, IL, USA). Descriptive statistics was performed by calculating the frequency, average, and standard deviation. The distribution of categorical variables was compared between the groups using the Chi-squared or Fisher’s exact test. The normality of the quantitative variables was measured using the Lilliefors test. Then, an independent Student’s <italic toggle="yes">t</italic>-test (for normally distributed data) and Mann–Whitney’s <italic toggle="yes">U</italic>-test (for non-normally distributed data) were used in the comparative analysis of serum markers between the VL/HIV and VL groups. The coefficient of multiple determination and the coefficient and standard error of each factor included in the model were estimated. For all analyses, a significance level of 5% was adopted.</p></sec><sec id="s2c4" hwp:id="sec-14"><title hwp:id="title-16">Ethical considerations</title><p hwp:id="p-13">The research project was registered at Plataforma Brasil, with ethical committee approval granted by Maranhão’s University Hospital (HUUFMA; date of approval: September 28, 2013, report number: 409.351). Retrospective data were obtained with permission from the ethics committee of HUUFMA and Health Department of the state of Maranhão without obtaining patient consent while maintaining confidentiality regarding the identities of the patients.</p></sec></sec></sec><sec id="s3" hwp:id="sec-15"><title hwp:id="title-17">RESULTS</title><p hwp:id="p-14">In total, 163 patients were evaluated in this study, including 126 patients with VL/HIV co-infection and 37 patients with VL alone. The demographic and social characteristics of the study groups are described in <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref>. Both groups consisted primarily of male patients. The mean age in the VL/HIV group was 36.9 ± 15 years (range, 19–50), compared to 30 ± 13.4 years (range, 19–66) in the VL group (<italic toggle="yes">p</italic> &lt; 0.001). In both groups, patients were primarily native individuals from Maranhão’s countryside.</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;403683v1/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-1"><title hwp:id="title-18">Sociodemographic variables of the studied groups</title></caption><graphic xlink:href="403683_tbl1" position="float" orientation="portrait" hwp:id="graphic-1"/><graphic xlink:href="403683_tbl1a" position="float" orientation="portrait" hwp:id="graphic-2"/></table-wrap><p hwp:id="p-15">The most frequent clinical complaints in the VL group, as showing in <xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">table 2</xref>, were fever (<italic toggle="yes">p</italic> &lt; 0.001) and hair loss (<italic toggle="yes">p</italic> = 0.007). The physical examination data revealed that weight loss (<italic toggle="yes">p</italic> = 0.003), fever (<italic toggle="yes">p</italic> &lt; 0001), jaundice (<italic toggle="yes">p</italic> &lt; 0.001), hepatomegaly (<italic toggle="yes">p</italic> = 0.029), and splenomegaly (<italic toggle="yes">p</italic> = 0.007) were more frequent in the VL group. In contrast, dyspnea was detected only in the VL/HIV group (<italic toggle="yes">p</italic> = 0.013). The frequency of skin/mucosal pallor was high in both groups (<italic toggle="yes">p</italic> = 0.920).</p><table-wrap id="tbl2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;403683v1/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-2"><title hwp:id="title-19">Clinical and physical examination data in the two groups</title></caption><graphic xlink:href="403683_tbl2" position="float" orientation="portrait" hwp:id="graphic-3"/><graphic xlink:href="403683_tbl2a" position="float" orientation="portrait" hwp:id="graphic-4"/></table-wrap><p hwp:id="p-16"><xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-1" hwp:rel-id="T3">Table 3</xref> shows the comparative analysis of the serum profiles between groups at the time of admission for VL treatment. The VL/HIV group exhibited a higher frequency of lymphocytopenia when compared to the VL group (<italic toggle="yes">p</italic> &lt; 0.001). Abnormal AST and ALT levels were observed more commonly in the VL group (<italic toggle="yes">p</italic> &lt; 0.001). Most co-infected patients had CD4 T-lymphocyte counts of less than 200 cells/mm<sup>3</sup> and viral loads of 50–9999 copies/mL, although the diagnosis of HIV came, in average, 2,6 years sooner than the one of VL in 81 patients (64.3%, <italic toggle="yes">p</italic> &lt; 0.001).</p><table-wrap id="tbl3" orientation="portrait" position="float" hwp:id="T3" hwp:rev-id="xref-table-wrap-3-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;403683v1/TBL3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T3</object-id><object-id pub-id-type="publisher-id">tbl3</object-id><label>Table 3.</label><caption hwp:id="caption-3"><title hwp:id="title-20">Laboratory data of the two groups</title></caption><graphic xlink:href="403683_tbl3" position="float" orientation="portrait" hwp:id="graphic-5"/><graphic xlink:href="403683_tbl3a" position="float" orientation="portrait" hwp:id="graphic-6"/><graphic xlink:href="403683_tbl3b" position="float" orientation="portrait" hwp:id="graphic-7"/><graphic xlink:href="403683_tbl3c" position="float" orientation="portrait" hwp:id="graphic-8"/></table-wrap><p hwp:id="p-17">The distribution of variables related to treatment is shown in <xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-1" hwp:rel-id="T4">Table 4</xref>. The most commonly used medicine in the VL/HIV group was liposomal amphotericin B (Amb-L), whereas it was <italic toggle="yes">N</italic>-methyl meglumine antimoniate (Sb<sup>v</sup>) in the VL group (<italic toggle="yes">p</italic> &lt; 0.001). The treatment time for VL was no more than 10 days in most patients in the co-infection group (<italic toggle="yes">p</italic> &lt; 0.001). In addition, 112 patients (88.9%) in the VL/HIV group remained hospitalized for more than a month, whereas no patients in the VL group were hospitalized (<italic toggle="yes">p</italic> &lt; 0.001). Furthermore, relapse occurred only in the co-infection group (<italic toggle="yes">p</italic> &lt; 0.001). Concerning antiretroviral treatment, highly active antiretroviral therapy was administered to all analyzed patients; most commonly a nucleoside reverse transcriptase inhibitor in combination with a non-nucleotide reverse transcriptase inhibitor or protease, including tenofovir + lamivudine in 113 (89.7%) patients, efavirenz in 54 patients (42.9%), and lopinavir/ritonavir in 52 patients (41.7%). Moreover, relapse (46 cases, 36.5%) and death (14, 11.1%) occurred only in the VL/HIV group.</p><table-wrap id="tbl4" orientation="portrait" position="float" hwp:id="T4" hwp:rev-id="xref-table-wrap-4-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;403683v1/TBL4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T4</object-id><object-id pub-id-type="publisher-id">tbl4</object-id><label>Table 4.</label><caption hwp:id="caption-4"><title hwp:id="title-21">VL treatment in the two groups</title></caption><graphic xlink:href="403683_tbl4" position="float" orientation="portrait" hwp:id="graphic-9"/><graphic xlink:href="403683_tbl4a" position="float" orientation="portrait" hwp:id="graphic-10"/></table-wrap></sec><sec id="s4" hwp:id="sec-16"><title hwp:id="title-22">DISCUSSION</title><p hwp:id="p-18">Visceral Leishmaniasis, an endemic disease in the northern and northeastern regions of Brazil, has changed in its epidemiological characteristics with the spread of HIV infection toward rural areas and coincidence of the diseases. In patients infected with HIV, VL can induce greater immunosuppression and stimulate viral replication, leading to a more aggravated condition and greater risks of relapse and death [<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>, <xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-2" hwp:rel-id="ref-2">2</xref>, <xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref>, <xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref>].</p><p hwp:id="p-19">VL/HIV co-infection displayed a heterogeneous casuistry among the Brazilian regions, but its incidence appears to be increasing across the country. The rates of co-infection according to Lindoso <italic toggle="yes">et al.</italic> were 0.7% in 2001 and 8.5% in 2012 [<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref>].</p><p hwp:id="p-20">Between 2007 and June 2017, data were collected for 127 patients with VL/HIV co-infection at the reference hospital where the study was performed. This cohort represented nearly 50% of all reported cases in the state of Maranhão through December 2016 [<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-2" hwp:rel-id="ref-12">12</xref>]. The finding of a higher incidence of VL in males in both VL with HIV and VL alone is supported by other findings, including epidemiological data from the Health Ministry, which reported that male patients accounted for 91.6% of all cases [<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-3" hwp:rel-id="ref-2">2</xref>,<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref>,<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref>]. Similarly, the finding that the mean age was lower in the VL group matches data reported by Hurissa <italic toggle="yes">et al.</italic>, who found that patients with VL alone had a mean age of 23.5 years. However, Cota <italic toggle="yes">et al.</italic> found no statistical difference in age between the VL/HIV and VL groups in a study of 90 patients [<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-2" hwp:rel-id="ref-24">24</xref>,<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>].</p><p hwp:id="p-21">The majority of diagnosed patients resided in Maranhão’s countryside, as corroborated by Furtado, who analyzed the residences of patients with VL in the state of Maranhão based on the National System for Reporting Harms, applying a method for risk identification, between 2000 and 2009. This analysis found that the incidence rates were higher in the cities of Caxias, Imperatriz, Presidente Dutra, Codó, and Barra do Corda, with attention also being devoted to the appearance of cases in countryside cities in which no VL case had been previously reported [<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref>]. By observing the internalization of VL, it is possible to perceive the juxtaposition that occurs between these VL infections found in people living with HIV an adequate environment to develop [<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref>].</p><p hwp:id="p-22">In line with our findings, Cota <italic toggle="yes">et al.</italic> described fever and hepatosplenomegaly as the most frequent complications in patients with VL alone. In contrast, Hurissa <italic toggle="yes">et al.</italic> found typical VL complications in both studied groups [<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-3" hwp:rel-id="ref-24">24</xref>,<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-2" hwp:rel-id="ref-25">25</xref>]. In their study, fever was observed more frequently in patients with VL than those with VL/HIV co-infection, group that presented this symptom in 52,4% of the patients, whereas this symptom was present in 100% of patients diagnosed in the state of Mato Grosso do Sul between 2000 and 2006 and 92% of patients diagnosed in the state of Ceará in 2015 [<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-2" hwp:rel-id="ref-23">23</xref>,<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref>]. Different from many Brazilian studies, which reported the presence of splenomegaly followed by fever, weight loss, and asthenia, in 81 patients with VL/HIV co-infection in Ceará [<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref>] and another study that identified weight loss, weakness, fever, and hepatosplenomegaly as the most common physical changes in 65 patients with VL/HIV co-infection [<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-2" hwp:rel-id="ref-13">13</xref>], the most common symptoms in this study were skin pallor, hepatomegaly, and splenomegaly, followed by fever and weight loss. In a systematic review of the epidemiological, clinical, and laboratory aspects of VL associated with HIV, the authors noted that the 10 most reported clinical manifestations in 15 studies were skin pallor, splenomegaly, fever, weight loss, hepatomegaly, couch, diarrhea, bleeding, asthenia, and jaundice [<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref>].</p><p hwp:id="p-23">Pancytopenia was observed in both studied groups, in contrast to the findings of Cota <italic toggle="yes">et al.</italic> and Hurissa <italic toggle="yes">et al.</italic>, who observed more pronounced thrombocytopenia in immunocompetent patients [<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-4" hwp:rel-id="ref-24">24</xref>,<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-3" hwp:rel-id="ref-25">25</xref>]. Pancytopenia related to HIV can be multifactorial due to direct effects of the virus, ineffectiveness of hematopoiesis, existence of an infiltrating disease in bone marrow, nutritional deficiencies, peripheral destruction, and toxic medication effects [<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref>]. In contrast, hematological alterations caused by VL are well known, as amastigote forms proliferate in the mononuclear phagocytic system, mainly in the spleen, liver, and bone marrow, resulting in disorders in phagocytic organs and producing hematological alterations. Tavora <italic toggle="yes">et al.</italic> observed pancytopenia in the majority of patients with VL/HIV co-infection [<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-2" hwp:rel-id="ref-28">28</xref>,<xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref>]. The finding of increased creatinine levels in less than 20% of cases in both groups was also reported by Mahajan <italic toggle="yes">et al.</italic>, who observed an increase in creatinine levels in 16 patients (5% of the patients with VL-HIV co-infection). Sinha <italic toggle="yes">et al.</italic>, who analyzed 49 patients with VL/HIV co-infection, found a mean creatinine level of 0.9 mg/mL. The increase in transaminase levels observed in some patients with VL/HIV co-infection [<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref>,<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref>,<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref>] was also found in the present study. However, we should note that such an increase was higher in patients with VL alone, as additionally reported by De Souza <italic toggle="yes">et al.</italic> and Cota <italic toggle="yes">et al.</italic> [<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-4" hwp:rel-id="ref-25">25</xref>,<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref>].</p><p hwp:id="p-24">CD4 T-lymphocytes were quantified by several authors who emphasized, similar to our study, the presence of immunosuppression with counts lower than 200 cells/mm<sup>3</sup> in a large portion of co-infected patients at the time of VL diagnosis [<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-3" hwp:rel-id="ref-23">23</xref>,<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-2" hwp:rel-id="ref-34">34</xref>,<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-2" hwp:rel-id="ref-35">35</xref>,<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref>,<xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref>]. However, we emphasize that the diagnosis of HIV having been performed before VL in most co-infected patients, these patients should be immunologically less suppressed since they would be taking antiretroviral, but most of them had a viral load above 50 copies. This may have been due to non-adherence to antiretroviral therapy, virological failure or worsening caused by VL infection, as it been shown that co-infected patients may have increased immunosuppression and stimulation of viral replication [<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-2" hwp:rel-id="ref-8">8</xref>].</p><p hwp:id="p-25">Treatment for VL was administered according to the Health Ministry protocol, with AmB-L being the drug of choice for patients with VL/HIV co-infection starting in 2015, whereas Sb<sup>v</sup> was used to treat patients with nonserious VL [<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-4" hwp:rel-id="ref-2">2</xref>]. Brazilian authors have reported treatments that reflect guidance from the Health Ministry, drawing attention to the adverse effects of AmB such as kidney toxicity and reactions during infusion. Toxicities linked to Sb<sup>v</sup> administration were also reported, in some cases requiring substitution with AmB. Some of the reports cited pancreatitis and cardiotoxicity [<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-4" hwp:rel-id="ref-23">23</xref>,<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-5" hwp:rel-id="ref-25">25</xref>,<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-2" hwp:rel-id="ref-36">36</xref>,<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref>]. The treatment duration for VL varied according to the therapeutic response using the criteria adopted by the Health Ministry, which call for a minimum duration of 10 days [<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-2" hwp:rel-id="ref-19">19</xref>]. However, we observed therapeutic failure, even after increasing the duration of AmB-L administration, making supplemental therapy with Sb<sup>v</sup> necessary (data not cited). AmB-L has been considered promising for the treatment of VL/HIV co-infection since 1999, when it was approved by the FDA [<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref>]. However, although it is associated with fewer side effects than AmB, VL/HIV co-infection remains to be associated with high rates of recurrence, as noted in the current study. Lindoso <italic toggle="yes">et al.</italic> noted that no standard therapeutic regimes have been developed for VL in the United States [<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-2" hwp:rel-id="ref-22">22</xref>]. Cota <italic toggle="yes">et al.</italic> reported recurrence and mortality rates of 37 and 8.7%, respectively, in a group of 46 patients with VL/HIV co-infection, compared to those of 2.5 and 4.7%, respectively, in 44 patients with VL. In a sample of 128 patients with VL, Oliveira reported recurrence and death rates of 7.8 and 4.7%, respectively. This result differs from that of the present study, in which no case of recurrence or death was reported among patients with VL mono-infection versus a mortality rate of 11.1% among patients with VL/HIV co-infection [<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-6" hwp:rel-id="ref-25">25</xref>,<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref>].</p><p hwp:id="p-26">This study had several limitations. Because of the use of secondary data, mainly in the retrospective study, incomplete data were obtained in some examinations. Another limitation was difficulty in analyzing some laboratory data, which precluded comparative analyses between the two groups, although we observed that the co-infection group patients had a lower rate of positivity in serological or rapid tests than the group without co-infection. Another limitation was the lower number of patients with VL alone. This finding was due to the lack of information in the medical records of these patients, as most of them were diagnosed in this referral hospital and subsequently referred for treatment at locations closer to their places of residence. On the contrary, the patients with VL/HIV co-infection in this study represented almost half of the 256 cases of co-infection in the state of Maranhão over the period of 2007–2016. We included patients only for whom complete data were available, increasing the statistical power of the analyses.</p><p hwp:id="p-27">In summary, our study found that VL is a public health issue in northeastern Brazil, especially in Maranhão, where its incidence is increasing. The severity of the disease is greater due to co-infection with HIV, which modifies the epidemiology and clinical presentation of VL. Thus, the classical triad of fever, paleness, and hepatosplenomegaly was not expected. We also concluded that treatment remains challenging, despite advances in antiretroviral treatment, so a definitive response to treatment for VL cannot be predicted when the disease is associated with HIV.</p></sec></body><back><sec id="s5" sec-type="supplementary-material" hwp:id="sec-17"><title hwp:id="title-23">SUPPORTING INFORMATION</title><p hwp:id="p-28">S1 Checklist: STROBE Checklist</p></sec><ack hwp:id="ack-1"><title hwp:id="title-24">Acknowledgments</title><p hwp:id="p-29">We thank Fundação de Amparo a Pesquisa do Maranhão (FAPEMA), Presidente Vargas Hospital, and Maranhão Health Secretariat.</p></ack><ref-list hwp:id="ref-list-1"><title hwp:id="title-25">REFERENCES</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Boer MD"><surname>Boer</surname> <given-names>MD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Davidson RN"><surname>Davidson</surname> <given-names>RN</given-names></string-name>. <article-title hwp:id="article-title-2">Treatment options for visceral leishmaniasis</article-title>. <source hwp:id="source-1">Rev Anti Infect Ther</source>. <year>2006</year>;<volume>4</volume>: <fpage>187</fpage>–<lpage>197</lpage>. doi: <pub-id pub-id-type="doi">10.1586/14787210.4.2.187</pub-id>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1 xref-ref-2-2 xref-ref-2-3 xref-ref-2-4"><label>2.</label><citation publication-type="book" citation-type="book" ref:id="403683v1.2" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-2"><collab hwp:id="collab-1">Brasil</collab>. <chapter-title>Ministério da Saύde. Secretaria de Vigilância em Saύde. Departamento de Vigilância das Doenças Transmissíveis</chapter-title>. <source hwp:id="source-2">Manual de recomendações para diagnóstico, tratamento e acompanhamento de pacientes com a coinfecção leishmania-HIV</source>. <publisher-loc>Brasília</publisher-loc>: <edition>1. ed.</edition>, rev. e ampl. <year>2015</year>. [In Portuguese]</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><label>3.</label><citation publication-type="book" citation-type="book" ref:id="403683v1.3" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-3"><collab hwp:id="collab-2">Brasil</collab>. <chapter-title>Ministério da Saύde. Vigilância em Saύde. Departamento de DST/Aids e Hepatites Virais</chapter-title>. <source hwp:id="source-3">Boletim Epidemiológico - Aids e DST. Ano V - n° 1 - até semana epidemiológica 26ª</source>. <publisher-loc>Brasília</publisher-loc>. <year>2016</year>. [In Portuguese]</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="de Souza CC"><surname>de Souza</surname> <given-names>CC</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Mata LRF"><surname>de Mata</surname> <given-names>LRF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Azevedo C"><surname>Azevedo</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gomes CRG"><surname>Gomes</surname> <given-names>CRG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cruz GEC"><surname>Cruz</surname> <given-names>GEC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Toffano SE"><surname>Toffano</surname> <given-names>SE</given-names></string-name>. <article-title hwp:id="article-title-3">Interiorização do HIV/Aids no Brasil: Um estudo epidemiológico. Revista Brasileira de Ciências da Saύde</article-title>. <year>2012</year>. <source hwp:id="source-4">Ano 11. N°</source> <volume>35</volume>:<fpage>25</fpage>–<lpage>30</lpage>. [In Portuguese]</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Alvar J"><surname>Alvar</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vélez ID"><surname>Vélez</surname> <given-names>ID</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bern C"><surname>Bern</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Herrero M"><surname>Herrero</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Desjeux P"><surname>Desjeux</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cano J"><surname>Cano</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-4">Leishmaniasis Worldwide and Global Estimates of Its Incidence</article-title>. <source hwp:id="source-5">PLoS ONE</source>. <year>2012</year>;<volume>7</volume>: <fpage>e35671</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0035671</pub-id>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Barbosa IR"><surname>Barbosa</surname> <given-names>IR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Neto RDS"><surname>Neto</surname> <given-names>RDS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Souza PP"><surname>Souza</surname> <given-names>PP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Silva RA"><surname>Silva</surname> <given-names>RA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lima SR"><surname>Lima</surname> <given-names>SR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cruz ID"><surname>Cruz</surname> <given-names>ID</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-5">Aspectos da coinfecção Leishmaniose Visceral e HIV no nordeste do Brasil</article-title>. <source hwp:id="source-6">Rev. Baiana de Saύde Pύblica</source>. <year>2013</year>;<volume>37</volume>: <fpage>672</fpage>-<lpage>687</lpage>. [In Portuguese]</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="De la Loma A"><surname>De la Loma</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alvar J"><surname>Alvar</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Galiano EM"><surname>Galiano</surname> <given-names>EM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Blázquez J"><surname>Blázquez</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Muñoz AA"><surname>Muñoz</surname> <given-names>AA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nájera R."><surname>Nájera</surname> <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-6">Leishmaniasis or AIDS?</article-title> <source hwp:id="source-7">Trans R Soc Trop Med Hyg</source>. <year>1985</year>;<volume>79</volume>: <fpage>421</fpage>–<lpage>422</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0035-9203(85)90400-6</pub-id>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1 xref-ref-8-2"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Alvar J"><surname>Alvar</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aparicio P"><surname>Aparicio</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aseffa A"><surname>Aseffa</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Den Boer M"><surname>Den Boer</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Canavate C"><surname>Canavate</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dedet JP"><surname>Dedet</surname> <given-names>JP</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-7">The. relationship between leishmaniasis and AIDS: the second 10 years</article-title>. <source hwp:id="source-8">Clin Microbiol Rev</source>. <year>2008</year>;<volume>21</volume>: <fpage>334</fpage>–<lpage>359</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Nicodemo EL"><surname>Nicodemo</surname> <given-names>EL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Duarte MIS"><surname>Duarte</surname> <given-names>MIS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Corbett CEP"><surname>Corbett</surname> <given-names>CEP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nicodemo AC"><surname>Nicodemo</surname> <given-names>AC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mata VLR"><surname>Mata</surname> <given-names>VLR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chebabo R"><surname>Chebabo</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-8">Visceral leishmaniasis in AIDS patient</article-title>. <source hwp:id="source-9">Rev Inst Med Trop S Paulo</source>. <year>1990</year>;<volume>32</volume>: <fpage>310</fpage>–<lpage>311</lpage>. doi: <pub-id pub-id-type="doi">10.1590/S0036-46651990000400013</pub-id>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><label>10.</label><citation publication-type="book" citation-type="book" ref:id="403683v1.10" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-10"><collab hwp:id="collab-3">Pan American Health Organization, WHO</collab>. <source hwp:id="source-10">Leishmaniases: epidemiological report of the Americas</source>. <publisher-loc>Washington, D.C</publisher-loc>: <publisher-name>Pan American Health Organization, World Health Organization</publisher-name>. <year>2017</year></citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Leite de Sousa-Gomes M"><surname>Leite de Sousa-Gomes</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Romero GAS"><surname>Romero</surname> <given-names>GAS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Werneck GL"><surname>Werneck</surname> <given-names>GL</given-names></string-name>. <article-title hwp:id="article-title-9">Visceral Leishmaniasis and HIV/AIDS in Brazil: Are we aware enough?</article-title> <source hwp:id="source-11">PLoS Negl Trop Dis</source>. <year>2017</year>;<volume>11</volume>:<fpage>e0005772</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0005772</pub-id>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1 xref-ref-12-2"><label>12.</label><citation publication-type="book" citation-type="book" ref:id="403683v1.12" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-12"><collab hwp:id="collab-4">Secretaria Estadual de Saύde do Maranhão</collab>. <chapter-title>Departamento de Controle de Zoonoses</chapter-title>. <source hwp:id="source-12">Programa de Vigilância e Controle da Leishmaniose. Situação epidemiológica da Leishmaniose Visceral e Tegumentar, no estado do Maranhão, 2007 a 2017</source>. <publisher-loc>Maranhão</publisher-loc>. <publisher-name>Estado do Maranhão</publisher-name>. <year>2017</year> [In Portuguese]</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1 xref-ref-13-2"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Viana GMC"><surname>Viana</surname> <given-names>GMC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Neto da Silva MAC"><surname>Neto da Silva</surname> <given-names>MAC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Garcia JVS"><surname>Garcia</surname> <given-names>JVS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Guimarães HD"><surname>Guimarães</surname>, <given-names>HD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Arcos Junior GF"><surname>Arcos Junior</surname> <given-names>GF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Santos AVA"><surname>Santos</surname> <given-names>AVA</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-10">Epidemiological profile of patients co-infected with visceral leishmaniasis and HIV/AIDS in Northeast, Brazil</article-title>. <source hwp:id="source-13">Rev Soc Bras Med Trop</source>. <year>2017</year>;<volume>50</volume>:<fpage>613</fpage>–<lpage>620</lpage>. doi: <pub-id pub-id-type="doi">10.1590/0037-8682-0494</pub-id>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14.</label><citation publication-type="book" citation-type="book" ref:id="403683v1.14" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-14"><collab hwp:id="collab-5">Brasil</collab>. <chapter-title>Ministério da Saύde. Secretaria de Vigilância em Saύde</chapter-title>. <source hwp:id="source-14">Leishmaniose visceral grave: normas e condutas</source>. <publisher-loc>Brasília</publisher-loc>. <publisher-name>Editora do Ministério da Saύde</publisher-name>, <year>2006</year>.[In Portuguese]</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Carranza-Tamayo CO"><surname>Carranza-Tamayo</surname> <given-names>CO</given-names></string-name>, <string-name name-style="western" hwp:sortable="Assis TS"><surname>Assis</surname> <given-names>TS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Neri ATB"><surname>Neri</surname> <given-names>ATB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cupolillo E"><surname>Cupolillo</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rabello A"><surname>Rabello</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Romero GA"><surname>Romero</surname> <given-names>GA</given-names></string-name>. <article-title hwp:id="article-title-11">Prevalence of <italic toggle="yes">Leishmania</italic> intection in adult HIV/AIDS patients treated in a tertiary-level care center in Brasilia. Federal District, Brazil</article-title>. <source hwp:id="source-15">Trans R Soc Trop Med Hyg</source>. <year>2009</year>;<volume>103</volume>: <fpage>743</fpage>–<lpage>748</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.trstmh.2009.01.014</pub-id>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Duxbury RE"><surname>Duxbury</surname> <given-names>RE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sadun EH"><surname>Sadun</surname> <given-names>EH</given-names></string-name>. <article-title hwp:id="article-title-12">Fluorescent antibody test for the serodiagnosis of visceral leishmaniasis</article-title>. <source hwp:id="source-16">Am J Trop Med Hyg</source>. <year>1964</year>;<volume>13</volume>: <fpage>525</fpage>–<lpage>529</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.1964.13.525</pub-id>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Cahil KM"><surname>Cahil</surname>, <given-names>KM</given-names></string-name>. <article-title hwp:id="article-title-13">Field technique in the diagnosis of calazar</article-title>. <source hwp:id="source-17">Trans R Soc Trop Med Hyg</source>.<year>1970</year>;<volume>83</volume>: <fpage>499</fpage>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Ho M"><surname>Ho</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Leeuwenburg J"><surname>Leeuwenburg</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mbugua G"><surname>Mbugua</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wamachi A"><surname>Wamachi</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Voller A."><surname>Voller</surname> <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-14">An enzyme-linked immunosorbent assay (ELISA) for field diagnosis of visceral leishmaniasis</article-title>. <source hwp:id="source-18">Am J Trop Med Hyg</source>. <year>1983</year>;<volume>32</volume>: <fpage>943</fpage>–<lpage>946</lpage>. doi: <pub-id pub-id-type="doi">10.4269/ajtmh.1983.32.943</pub-id>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1 xref-ref-19-2"><label>19.</label><citation publication-type="book" citation-type="book" ref:id="403683v1.19" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-19"><collab hwp:id="collab-6">Brasil</collab>. <chapter-title>Ministério da Saύde. Secretaria de vigilância em saύde</chapter-title>. <source hwp:id="source-19">Departamento de vigilância epidemiológica. Manual de vigilância e controle da leishmaniose visceral</source>. <year>2014</year>. <publisher-loc>Brasília</publisher-loc>. 1 ed. 5° reimpressão. [In Portuguese]</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Alvar J"><surname>Alvar</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Canavate C"><surname>Canavate</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gutiérrez-Solar B"><surname>Gutiérrez-Solar</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jiménez M"><surname>Jiménez</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Laguna F"><surname>Laguna</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="López-Vélez R"><surname>López-Vélez</surname> <given-names>R</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-15">Leishmania and human immunodeficiency virus coinfection: the first 10 years</article-title>. <source hwp:id="source-20">Clin Microbiol Rev</source>. <year>1997</year>;<volume>2</volume>: <fpage>334</fpage>–<lpage>359</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Cruz I"><surname>Cruz</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nieto J"><surname>Nieto</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Moreno J"><surname>Moreno</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cañavate C"><surname>Cañavate</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Desjeux P"><surname>Desjeux</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alvar J"><surname>Alvar</surname> <given-names>J</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-16">Leishmania/HIV co-nfections in the second decade</article-title>. <source hwp:id="source-21">Indian J Med Res</source>. <year>2006</year>;<volume>123</volume>:<fpage>357</fpage>–<lpage>388</lpage>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1 xref-ref-22-2"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Lindoso JA"><surname>Lindoso</surname> <given-names>JA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cota GF"><surname>Cota</surname> <given-names>GF</given-names></string-name>, <string-name name-style="western" hwp:sortable="da Cruz AM"><surname>da Cruz</surname> <given-names>AM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goto H"><surname>Goto</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Maia-Elkhoury AN"><surname>Maia-Elkhoury</surname> <given-names>AN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Romero GA"><surname>Romero</surname> <given-names>GA</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-17">Visceral leishmaniasis and HIV coinfection in Latin America</article-title>. <source hwp:id="source-22">PLoS Negl Trop Dis</source>.<year>2014</year>;<volume>8</volume>: <fpage>e3136</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0003136</pub-id>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1 xref-ref-23-2 xref-ref-23-3 xref-ref-23-4"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Alexandrino-de-Oliveira P"><surname>Alexandrino-de-Oliveira</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Santos-Oliveira JR"><surname>Santos-Oliveira</surname> <given-names>JR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dorval ME"><surname>Dorval</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Da-Costa FD"><surname>Da-Costa</surname> <given-names>FD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pereira GR"><surname>Pereira</surname> <given-names>GR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cunha RV"><surname>Cunha</surname> <given-names>RV</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-18">HIV/AIDS-associated visceral leishmaniasis in patients from na endemic área in central-west Brazil</article-title>. <source hwp:id="source-23">Memórias do Instituto Oswaldo Cruz</source>.<year>2010</year>;<volume>105</volume>: <fpage>692</fpage>–<lpage>697</lpage>. doi: <pub-id pub-id-type="doi">10.1590/S0074-02762010000500016</pub-id>.</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1 xref-ref-24-2 xref-ref-24-3 xref-ref-24-4"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Hurissa Z"><surname>Hurissa</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gebre-Silassie S"><surname>Gebre-Silassie</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hailu W"><surname>Hailu</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tefera T"><surname>Tefera</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lallo DG"><surname>Lallo</surname> <given-names>DG</given-names></string-name>, <string-name name-style="western" hwp:sortable="al Cuevas LE et"><given-names>Cuevas LE et</given-names> <surname>al</surname></string-name>. <article-title hwp:id="article-title-19">Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia</article-title>. <source hwp:id="source-24">Trop Med Int Health</source>. <year>2010</year>;<volume>15</volume>: <fpage>848</fpage>–<lpage>855</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-3156.2010.02550.x</pub-id>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1 xref-ref-25-2 xref-ref-25-3 xref-ref-25-4 xref-ref-25-5 xref-ref-25-6"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Cota GF"><surname>Cota</surname> <given-names>GF</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Sousa MR"><surname>de Sousa</surname> <given-names>MR</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Sousa MR"><surname>de Sousa</surname> <given-names>MR</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Mendonça ALP"><surname>de Mendonça</surname> <given-names>ALP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Patrocinio A"><surname>Patrocinio</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Assunção LS"><surname>Assunção</surname> <given-names>LS</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-20">Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil</article-title>. <source hwp:id="source-25">PLoS Negl Trop Dis</source>. <year>2014</year>;<volume>8</volume>: <fpage>e2816</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pntd.0002816</pub-id>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><label>26.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Furtado AS"><surname>Furtado</surname> <given-names>AS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nunes FBBF"><surname>Nunes</surname> <given-names>FBBF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Santos AM"><surname>Santos</surname> <given-names>AM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Caldas AJM"><surname>Caldas</surname> <given-names>AJM</given-names></string-name>. <article-title hwp:id="article-title-21">Análise espaço-temporal da leishmaniose visceral no estado do Maranhão</article-title>. <source hwp:id="source-26">Brasil. Ciências &amp; Saύde Coletiva</source>. <year>2015</year>;<volume>20</volume>: <fpage>3935</fpage>–<lpage>3942</lpage>. doi: <pub-id pub-id-type="doi">10.1590/1413-812320152012.01672015</pub-id>.[In Portuguese]</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1"><label>27.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Maia-Elkhoury NA"><surname>Maia-Elkhoury</surname> <given-names>NA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alves WA"><surname>Alves</surname> <given-names>WA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sousa-Gomes ML"><surname>Sousa-Gomes</surname> <given-names>ML</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sena JM"><surname>Sena</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Luna EA"><surname>Luna</surname> <given-names>EA</given-names></string-name>. <article-title hwp:id="article-title-22">Visceral leishmaniases in Brazil: Trends and challenges</article-title>. <source hwp:id="source-27">Cad Saude Pύblica</source>. <year>2008</year>;<volume>24</volume>: <fpage>2941</fpage>–<lpage>2947</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1 xref-ref-28-2"><label>28.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Távora LGF"><surname>Távora</surname> <given-names>LGF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nogueira MB"><surname>Nogueira</surname> <given-names>MB</given-names></string-name> and <string-name name-style="western" hwp:sortable="Gomes ST"><surname>Gomes</surname> <given-names>ST</given-names></string-name>. <article-title hwp:id="article-title-23">Visceral leishmaniasis/HIV co-infection in northeast Brazil: evaluation of outcome</article-title>. <source hwp:id="source-28">Braz J Infect Dis</source>. <year>2015</year>;<volume>20</volume>: <fpage>286</fpage>–<lpage>299</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bjid.2015.07.004</pub-id>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><label>29.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Henn GA"><surname>Henn</surname> <given-names>GA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ramos Junior AN"><surname>Ramos Junior</surname> <given-names>AN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Colares JK"><surname>Colares</surname> <given-names>JK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mendes LP"><surname>Mendes</surname> <given-names>LP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Silveira JG"><surname>Silveira</surname>, <given-names>JG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lima AA"><surname>Lima</surname> <given-names>AA</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-24">Is visceral leishmaniasis the same in HIV-coinfected adults?</article-title> <source hwp:id="source-29">Braz J Infect Dis</source>.<year>2018</year>;<volume>22</volume>: <fpage>92</fpage>–<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bjid.2018.03.001</pub-id>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Graepp Fontoura I"><surname>Graepp Fontoura</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Soeiro Barbosa D"><surname>Soeiro Barbosa</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Paes AMA"><surname>Paes</surname> <given-names>AMA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Santos FS"><surname>Santos</surname> <given-names>FS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Santos Neto M"><surname>Santos Neto</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fontoura VM"><surname>Fontoura</surname> <given-names>VM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-25">Epidemiological, clinical and laboratory aspects of human visceral leishmaniasis (HVL) associated with human immunodeficiency vírus (HIV) coinfection: a systematic review</article-title>. <source hwp:id="source-30">Parasitology</source>. <year>2018</year>; <fpage>1</fpage>–<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S003118201800080X</pub-id>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Grossman V"><surname>Grossman</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Herberman RB"><surname>Herberman</surname> <given-names>RB</given-names></string-name>. <article-title hwp:id="article-title-26">T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host</article-title>. <source hwp:id="source-31">Nat Med</source>.<year>1997</year>;<volume>3</volume>: <fpage>486</fpage>–<lpage>490</lpage>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Varma N"><surname>Varma</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Naseen S."><surname>Naseen</surname> <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-27">Hematologic changes in visceral leishmaniasis/Kala Azar</article-title>.<source hwp:id="source-32">Indian J Hematol Blood Transfus</source>. <year>2010</year>;<volume>26</volume>: <fpage>78</fpage>–<lpage>82</lpage>.</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Mahajan R"><surname>Mahajan</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Das P"><surname>Das</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Isaakidis P"><surname>Isaakidis</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sunyoto T"><surname>Sunyoto</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sagili KD"><surname>Sagili</surname> <given-names>KD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lima MA"><surname>Lima</surname> <given-names>MA</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-28">Combination treatment for visceral leishmaniasis patients coinfected with human immunodeficiency virus in India</article-title>. <source hwp:id="source-33">Clin Infect Dis</source>. <year>2015</year>;<volume>8</volume>: <fpage>1255</fpage>–<lpage>1262</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/civ530</pub-id>.</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1 xref-ref-34-2"><label>34.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Sinha PK"><surname>Sinha</surname> <given-names>PK</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Griensven J"><surname>van Griensven</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pandey K"><surname>Pandey</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kumar N"><surname>Kumar</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Verma N"><surname>Verma</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mahajan R"><surname>Mahajan</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-29">Lipossomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India</article-title>. <source hwp:id="source-34">Clin Infect Dis</source>.<year>2015</year>;<volume>53</volume>: <fpage>e91</fpage>–<lpage>e98</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cid/cir521</pub-id></citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1 xref-ref-35-2"><label>35.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Lima IP"><surname>Lima</surname> <given-names>IP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Müller MC"><surname>Müller</surname> <given-names>MC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Holanda TA"><surname>Holanda</surname> <given-names>TA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Harhay M"><surname>Harhay</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Costa CH"><surname>Costa</surname> <given-names>CH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Costa DL"><surname>Costa</surname> <given-names>DL</given-names></string-name>. <article-title hwp:id="article-title-30">Human immunodeficiency virus/Leishmania infantum in the first foci of urban American Visceral leishmaniasis: clinical presentation from 1994 to 2010</article-title>. <source hwp:id="source-35">Rev Soc Bras Med Trop</source>. <year>2013</year>; <volume>46</volume>: <fpage>156</fpage>–<lpage>160</lpage>. doi: <pub-id pub-id-type="doi">10.1590/0037-8682-0033-2012</pub-id>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1 xref-ref-36-2"><label>36.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="de Sousa GF"><surname>de Sousa</surname> <given-names>GF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Biscione F"><surname>Biscione</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Greco DB"><surname>Greco</surname> <given-names>DB</given-names></string-name> and <string-name name-style="western" hwp:sortable="Rabelo A."><surname>Rabelo</surname> <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-31">Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients</article-title>. <source hwp:id="source-36">Rev Soc Bras Med Trop</source>.<year>2012</year>;<volume>45</volume>: <fpage>147</fpage>–<lpage>150</lpage>. doi: <pub-id pub-id-type="doi">10.1590/S0037-86822012000200001</pub-id>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><label>37.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Bourgeois N"><surname>Bourgeois</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lachaud L"><surname>Lachaud</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Reynes J"><surname>Reynes</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rouanet I"><surname>Rouanet</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mahamat A"><surname>Mahamat</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bastien P."><surname>Bastien</surname> <given-names>P.</given-names></string-name> <article-title hwp:id="article-title-32">Long term monitoring of visceral leishmaniasis in patients with AIDS</article-title>. <source hwp:id="source-37">J Acquir Immune Defic Syndr</source>. <year>2008</year>;<volume>48</volume>: <fpage>13</fpage>-<lpage>19</lpage>. e0005772. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0005772</pub-id>.</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>38.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Diro E"><surname>Diro</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lynen L"><surname>Lynen</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mohammed R"><surname>Mohammed</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Boelaert M"><surname>Boelaert</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hailu A"><surname>Hailu</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Griensven J."><surname>van Griensven</surname> <given-names>J.</given-names></string-name> <article-title hwp:id="article-title-33">High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia</article-title>. <source hwp:id="source-38">PLoS Negl Trop Dis</source>. <year>2014</year>;<volume>8</volume>: <fpage>e2875</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pntd.0002875</pub-id>.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Albuquerque LC"><surname>Albuquerque</surname> <given-names>LC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mendonça IR"><surname>Mendonça</surname> <given-names>IR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cardoso PN"><surname>Cardoso</surname> <given-names>PN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Baldaçara LR"><surname>Baldaçara</surname> <given-names>LR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Borges MR"><surname>Borges</surname> <given-names>MR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Borges JD"><surname>Borges</surname> <given-names>JD</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-34">HIV/AIDS - related visceral leishmaniasis: a clinical and epidemiological descrition</article-title>. <source hwp:id="source-39">Rev Soc Bras Med Trop</source>. <year>2014</year>;<volume>47</volume>: <fpage>38</fpage>–<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1590/0037-8682-0180-2013</pub-id>.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><label>40.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Meyerhoff A."><surname>Meyerhoff</surname>, <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-35">US Food and drug administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis</article-title>. <source hwp:id="source-40">Clin Infect Dis</source>. <year>1999</year>;<volume>28</volume>: <fpage>42</fpage>–<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1086/515085</pub-id>.</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><label>41.</label><citation publication-type="journal" citation-type="journal" ref:id="403683v1.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Oliveira EN"><surname>Oliveira</surname> <given-names>EN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pimenta AM"><surname>Pimenta</surname> <given-names>AM</given-names></string-name>. <article-title hwp:id="article-title-36">Perfil epidemiológico das pessoas portadoras de leishmaniose visceral no município de Paracatu-MG no período de 2007 a 2010</article-title>. <source hwp:id="source-41">Rev Min Enferm</source>. <year>2014</year>;<volume>18</volume>: <fpage>365</fpage>–<lpage>370</lpage>. doi: <pub-id pub-id-type="doi">10.5935/1415-2762.20140028</pub-id>. [In Portuguese]</citation></ref></ref-list></back></article>
